论文部分内容阅读
目的观察沙美特罗替卡松治疗儿童哮喘的临床疗效。方法将69例哮喘患儿随机分为观察组和对照组,分别应用沙美特罗替卡松和布地奈德气雾剂治疗1年6个月,观察两组患儿哮喘发作次数及治疗前后肺功能(FEV1和PEF预计值%)的变化。结果观察组哮喘急性发作次数明显减少,与对照组差异有统计学意义(P<0.001),两组均可提高FEV1和PEF预计值%,改善肺功能(P均<0.001)。结论沙美特罗替卡松吸入对儿童哮喘有良好的治疗作用。
Objective To observe the clinical efficacy of salmeterol and fluticasone in the treatment of childhood asthma. Methods Sixty-nine children with asthma were randomly divided into observation group and control group. The patients were treated with salmeterol and rosuvastatin aerosol respectively for 1 year and 6 months. The number of asthma attacks and the pulmonary Changes in function (% predicted FEV1 and PEF). Results The number of acute exacerbation of asthma in observation group was significantly decreased (P <0.001). Both groups could improve the predicted value of FEV1 and PEF and improve pulmonary function (all P <0.001). Conclusions Salmeterol and terbutaline may have a good therapeutic effect on asthma in children.